feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Millions of Typhoid Cases Hit India; Antibiotic Resistance Worsens

Millions of Typhoid Cases Hit India; Antibiotic Resistance Worsens

8 Jan

•

Summary

  • Estimated 49 lakh typhoid cases and 7,850 deaths occurred in India in 2023.
  • Fluoroquinolone-resistant strains caused six lakh of the 7.3 lakh hospitalisations.
  • Delhi, Maharashtra, and Karnataka show the highest typhoid burden and resistance.
Millions of Typhoid Cases Hit India; Antibiotic Resistance Worsens

A recent study estimates that India recorded approximately 49 lakh cases of typhoid fever and 7,850 deaths in 2023. Delhi, Maharashtra, and Karnataka together account for nearly 30% of the national typhoid burden, also exhibiting the highest rates of fluoroquinolone-resistant infections.

Antimicrobial resistance, particularly to fluoroquinolones, is a critical driver of hospitalizations, with six lakh of the total 7.3 lakh cases attributed to this resistance. While resistance to some antibiotics remains low, fluoroquinolone resistance has shown a concerning upward trend, peaking at 94% in 2017.

Researchers highlight the need for prompt action, suggesting Delhi, Maharashtra, and Karnataka as priority states for typhoid conjugate vaccine introduction. They also emphasize that antimicrobial resistance control measures are crucial for managing the escalating crisis effectively.

trending

Shots fired near CDC HQ

trending

Rocket Lab stock soars

trending

Xavier Worthy successful shoulder surgery

trending

Micron invests $100B in NY

trending

Walton Goggins felt 'depleted'

trending

Georgia snow this weekend

trending

Orlando cold snap incoming

trending

UDA Nationals dance competition

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
A study estimated 49 lakh typhoid fever cases and 7,850 deaths in India for 2023.
Delhi, Maharashtra, and Karnataka show the highest typhoid burden and fluoroquinolone-resistant cases and deaths.
Fluoroquinolone-resistance is linked to a significant majority of typhoid-related hospitalizations and deaths across India.

Read more news on

Indiaside-arrowHealthside-arrowKarnatakaside-arrowMaharashtraside-arrow

You may also like

Nipah Virus Fear: Central India Cleared of Cases

15 hours ago • 10 reads

article image

Bengal's Nipah Fight: Doctors Recall 2001 Deadly Outbreak

1 day ago • 26 reads

article image

India Marks 15 Years Polio-Free: A Global Health Triumph

13 Jan • 38 reads

article image

Typhoid Surge: India Battles Rising Fever Outbreak

9 Jan • 49 reads

article image

Gujarat Reports First CCHF Case of 2026

9 Jan • 49 reads

article image